Abstract for the 3rd EDRN-Gordon Research Conference (GRC) on New Frontiers in Cancer Detection and Diagnosis, presenting clincal results of CAM technology.

Multiple marker identification of rare tumor cells in blood and ascites of patients with metastatic diseases.

Expression profiles of tumor-associated genes in viable tumor cells isolated from primary tumors, ascites and blood of patients with adenocarcinomas of the ovary.

A novel detection technology for enrichment of rare and viable tumor cells in blood of patients with metastatic diseases.

Awarded as the first part of an STTR Fast Track grant from the National Cancer Institutes´ flagship program, " Innovative Molecular Analysis Technologies," the Vitatex project: “Cancer Detection Technologies” aimed to prove the utility of the Vita-Tech^TM platform technologies on gastro-intestinal cancers, particularly diseases of the pancreas and the colon. This Phase I project demonstrated the proof-of-principal for the Vita-Tech^TM platform technologies as a clinically useful assay for detection of gastro-intestinal cancers .

AACR Late-Breaking Abstract of the 2003 AACR Annual Meeting,  at the new Washington Convention Center in Washington, D.C.

In this National Cancer Institutes´ STTR Phase I application, we have optimized and validated a novel and rapid cell separation technology for enrichment of viable metastatic tumor cells from the ascites of patients with ovarian cancer. The approach yields highly purified viable tumor cells and tumor-associated leukocytes. This project provides a proof-of-principle demonstration of usefulness of Vitatex’s rare cell isolation technologies in molecular analysis of cancer gene signature.

Abstract presented at AACR October 2002 on Cell Adhesion Matrix technology used in an ECM model for the isolation and detection of invasive carcinoma cells with angiogenic and metastatic phenotypes from blood and tumor.

Abstract of an oral presentation given by Dr. Giulio Ghersi at the International Conference on DPPIV in September 2002 on Seprase-DPPIV Association for Prolyl Peptidase and Gelatinase Activities.

Abstract of an oral presentation given by Dr. Chen at the International Conference on DPPIV in September 2002 on the proetolytic activities of DPPIV and seprase in cancer invasion and angiogenesis.